ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "sleep and systemic lupus erythematosus (SLE)"

  • Abstract Number: 1644 • 2017 ACR/ARHP Annual Meeting

    Less Than Seven Hours of Sleep per Night Is Associated with Transitioning to Systemic Lupus Erythematosus

    Kendra A. Young1, Melissa E. Munroe2, Joel M. Guthridge3, Diane L. Kamen4, Gary S. Gilkeson5, Michael Weisman6, David Karp7, John B. Harley8, Daniel J. Wallace6, Judith A. James9 and Jill M. Norris10, 1Epidemiology, University of Colorado Denver, Aurora, CO, 2Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, OKC, OK, 4Medicine/Rheumatology & Immunology, Medical University of South Carolina, Charleston, SC, 5Department of Medicine, Medical University of South Carolina, Charleston, SC, 6Cedars-Sinai Medical Center Division of Rheumatology, Los Angeles, CA, 7Rheumatology, UT Southwestern Med Ctr, Dallas, TX, 8Center for Autoimmune Genomics and Etiology (CAGE), Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 9Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 10Department of Epidemiology, Colorado School of Public Health, Aurora, CO

    Background/Purpose: Systemic lupus erythematosus (SLE) is a complex autoimmune disease with a relatively unknown etiology. The quality and quantity of sleep has been shown to…
  • Abstract Number: 2820 • 2017 ACR/ARHP Annual Meeting

    Disease Activity By the Sledai in Lupus Patients Who Self Report Sleep Disturbance and Sleep Impairment Using the Patient-Reported Outcomes Measurement Information System Instruments

    Teresa Aberle1, Rufei Lu2, Sarah Cioli3, Stan Kamp1, Wade DeJager1, Stephen Apel4, Cristina Arriens5, Eliza Chakravarty6, Aikaterini Thanou1, Joel M. Guthridge7, Joan T. Merrill8 and Judith A. James9, 1Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Arthritis and Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 4Oklahoma Medical Research Foundation, Oklahoma City, OK, 5Arthritis & Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 6Oklahoma Medical research af, Edmond, OK, 7Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, OKC, OK, 8Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 9Arthritis & Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK

    Background/Purpose: Lupus patients commonly report sleep dysfunction, which is associated with upregulation of inflammatory cytokines in healthy people. Studies exploring relationships between self-reported sleep dysfunction…
  • Abstract Number: 2824 • 2017 ACR/ARHP Annual Meeting

    Sleep and Depression Mediate the Relationship between Pain and Cognitive Dysfunction in Lupus Patients

    Teresa A. Lillis1, Vanessa Tirone1, Stacy Weinberg2, Nisarg Gandhi3, Ailda Nika4, Winston Sequeira4, Stevan E. Hobfoll1, Joel A. Block2 and Meenakshi Jolly4, 1Behavioral Sciences, Rush University Medical Center, Chicago, IL, 2Division of Rheumatology, Rush University Medical Center, Chicago, IL, 3Rush University Medical Center, Chicago, IL, 4Rheumatology, Rush University Medical Center, Chicago, IL

    Background/Purpose: Cognitive Dysfunction (CD) is seen among 20-80% of patients with Systemic Lupus Erythematosus (SLE) and adversely affects their quality of life and productivity. Pain,…
  • Abstract Number: 1762 • 2016 ACR/ARHP Annual Meeting

    Systemic Lupus Erythematosus and the Evaluation of Poor Sleep

    Philip Chu1, Alicia Hinze2, Nancy Mathis3, Lacey Feigl4, Noor Al-Hammadi5, Seth Eisen6, Yo-El Ju7 and Alfred Kim8, 1Internal Medicine, Washington University School of Medicine, St Louis, MO, 2Johns Hopkins University, Baltimore, MD, 3Rheumatology, Washington University School of Medicine, Saint Louis, MO, 4Washington University School of Medicine, St Louis, MO, 5Division of Biostatistics, Washington University School of Medicine, St Louis, MO, 6Division of Rheumatology, Washington University School of Medicine, St Louis, MO, 7Neurology, Washington University School of Medicine, Saint Louis, MO, 8IM/Div of Rheumatology, Washington University School of Medicine, St. Louis, MO

    Background/Purpose:  Poor sleep quality is an underappreciated complaint commonly observed in patients with SLE. We hypothesize that poor sleep quality contributes to worsening lupus disease…
  • Abstract Number: 717 • 2015 ACR/ARHP Annual Meeting

    Systemic Lupus Erythematosus and the Evaluation of Poor Sleep: The Sleeps Pilot Study

    Alicia Hinze1, Philip Chu1, Dany Thekkemuriyil1, Yo-El Ju2, Deepali Sen3, Seth Eisen1 and Alfred Kim1, 1Rheumatology, Washington University School of Medicine, Saint Louis, MO, 2Neurology, Washington University School of Medicine, Saint Louis, MO, 3Division of Rheumatology, Washington University School of Medicine, Saint Louis, MO

    Background/Purpose: Sleep disturbances occur in many autoimmune diseases and are ranked highly as an unmet need in patients with SLE. We hypothesized that poor sleep…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology